Podcast
Patel Provides Insight Into Post-Transplant Complications in Myeloid Disorders
Author(s):
In Partnership With:
Dr Patel discusses post-transplant complications in myeloid disorders, the prevalence of these complications, and the most common ones that may arise, including primary disease relapse, graft-vs-host disease, infection, organ toxicity, persistent cytopenias, and immunosuppression.
Welcome to OncLive On Air®! I’m your host today, Ashling Wahner.
OncLive On Air® is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive® covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.
In today’s episode, we had the pleasure of speaking with Sagar Patel, MD, an assistant professor in the Blood and Marrow Transplant Program at the Huntsman Cancer Institute, University of Utah.
In our exclusive interview, Dr Patel joined us to discuss post-transplant complications in myelofibrosis and other myeloid disorders. In particular, he explained the prevalence of these complications and noted the most common ones that may arise in these populations, including primary disease relapse, graft-vs-host disease (GVHD), infection, organ toxicity, persistent cytopenias, and immunosuppression. Dr Patel also emphasized the treatments available for patients who relapse or develop GVHD after transplant, and laid out how GVHD management differs in patients who receive post-transplant cyclophosphamide vs those who receive general GVHD prophylaxis.
___
That’s all we have for today! Thank you for listening to this episode of OncLive On Air®. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.
For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.
OncLive® is also on social media. On Twitter, follow us at @OncLive and @OncLiveSOSS. On Facebook, like us at OncLive and OncLive State of the Science Summit and follow our OncLive page on LinkedIn.
If you liked today’s episode of OncLive On Air®, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!
Thanks again for listening to OncLive On Air®.
*OncLive On Air® is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.
